Proactive Disclosure

Disclosure of Travel and Hospitality Expenses

Dr. Brien Benoit, Chairperson and CEO

Travel Expenses - March 2, 2007 to June 1, 2007

Date(s)	Purpose	Total Cost
3/21/2007 to 3/21/2007	Hearing in the matter of Janssen-Ortho Inc. and the medicine Concerta	$15.28
3/28/2007 to 3/28/2007	Attendance before the Standing Committee on Health	$19.28
4/27/2007 to 4/27/2007	Hearing in the matter of Shire BioChem Inc. and the medicine Adderall XR	$9.32
4/30/2007 to 4/30/2007	Hearing in the matter of Shire BioChem Inc. and the medicine Adderall XR	$15.32
5/1/2007 to 5/1/2007	Executive Committee meeting	$15.32
5/16/2007 to 5/17/2007	Meeting on the Board's Review of its Excessive Price Guidelines	$38.64
5/18/2007 to 5/18/2007	Board Meeting	$15.32
5/24/2007 to 5/24/2010	Meeting on the Board's Excessive Price Guidelines	$8.32
5/29/2007 to 5/30/2007	Consultations on the Board's Excessive Price Guidelines	$901.30
	Total:	$1,038.10

Hospitality Expenses - March 2, 2007 to June 1, 2007

There are no hospitality expenses for this period.